Kras inhibitors

Adedoyin David Abraham, Thornton, CO (US);

Alberto Valero De La Cruz, Madrid, ES;

Alicia Marcos Llorente, Madrid, ES;

Alvaro Enriquez Garcia, Madrid, ES;

Andrew Dilger, Golden, CO (US);

Deqi Guo, Carmel, IN (US);

Desta Bume, Commerce City, CO (US);

Frederic Laurent Cordier, Madrid, ES;

Gaiying Zhao, Carmel, IN (US);

Isabel Rojo Garcia, Madrid, ES;

James Robert Henry, James City, FL (US);

Jason Eric Lamar, Indianapolis, IN (US);

Jolie Anne Bastian, Indianapolis, IN (US);

Maria Lourdes Prieto Vallejo, Madrid, ES;

Mario Barberis, Madrid, ES;

Matthew Patrick Baumgartner, Aldan, PA (US);

Miguel Garzón Sanz, Madrid, ES;

Pablo Garcia Losada, Madrid, ES;

Ramkumar Rajamani, Acton, MA (US);

Richard Duane Johnston, Greenfield, IN (US);

Robert Hazlitt, Broomfield, CO (US);

Santiago Carballares Martin, Madrid, ES;

Sean Aronow, Boulder, CO (US);

Shane Michael Walls, Broomfield, CO (US);

Sonia Maria Gutierrez Sanfeliciano, Carmel, IN (US);

Steven Andrews, Erie, CO (US);

Timothy Scott Kercher, Longmont, CO (US);

Victoriano Molero Flórez, Madrid, ES;

Wenceslao Lumeras Amador, Madrid, ES;

William Rush Scaggs, Broomfield, CO (US);

Juan Antonio Rincon Cabezudo, Madrid, ES;

Julián Priego Soler, Madrid, ES;

Xiaohong Chen, Broomfield, CO (US);

Eli Lilly and Company, Indianapolis, IN (US);